The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ETNB | +90.35% | -39.46% | -9.54% | -29% |
| S&P | +16.9% | +95.99% | +14.39% | +120% |
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.01M | 33.3% |
| Market Cap | $1.43B | 81.9% |
| Market Cap / Employee | $15.41M | 0.0% |
| Employees | 93 | 32.9% |
| Net Income | -$111.50M | -132.4% |
| EBITDA | -$115.82M | -116.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $129.08M | -39.2% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $36.84M | 68.8% |
| Short Term Debt | $0.78M | -85.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -75.94% | -43.4% |
| Return On Invested Capital | -51.21% | -4.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$100.43M | -64.2% |
| Operating Free Cash Flow | -$100.43M | -64.2% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.51 | 2.19 | 2.17 | 2.37 | 58.52% |
| Price to Tangible Book Value | 1.51 | 2.19 | 2.17 | 2.37 | 58.52% |
| Enterprise Value to EBITDA | -2.67 | -4.13 | -6.10 | -8.87 | 60.23% |
| Return on Equity | -73.3% | -78.3% | -69.3% | -86.9% | 138.00% |
| Total Debt | $37.57M | $37.55M | $37.58M | $37.62M | 37.56% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
